MET and neuroblastoma: We investigated the role of the MET gene in NB disease progression by analyzing 1235 NB primary patient data from three different patient datasets, including 88 patients in the Versteeg dataset, 649 patients in the Kocak dataset, and 498 patients in the SEQC dataset.